Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - XBiotech Inc. | ex_233699.htm |
| EX-32.2 - EXHIBIT 32.2 - XBiotech Inc. | ex_233704.htm |
| EX-31.1 - EXHIBIT 31.1 - XBiotech Inc. | ex_233701.htm |
| EX-31.2 - EXHIBIT 31.2 - XBiotech Inc. | ex_233702.htm |
| EX-4.1 - EXHIBIT 4.1 - XBiotech Inc. | ex_233697.htm |
| EX-32.1 - EXHIBIT 32.1 - XBiotech Inc. | ex_233703.htm |
| 10-K - FORM 10-K - XBiotech Inc. | xbit20201231_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-207476) pertaining to the 2005 Incentive Stock Option Plan and 2015 Equity Incentive Plan of XBiotech Inc.; and |
|
|
(2) |
Registration Statement (Form S-8 No. 333-249288) pertaining to the 2015 Equity Incentive Plan of XBiotech Inc. |
of our report dated March 16, 2021, with respect to the consolidated financial statements of XBiotech Inc. included in this Annual Report (Form 10-K) of XBiotech Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Austin, Texas
March 16, 2021